Overexpression of MN1 confers resistance to chemotherapy, accelerates leukemia onset, and suppresses p53 and Bim induction
about
Differential network analysis in human cancer researchThe efficacy of the ribonucleotide reductase inhibitor Didox in preclinical models of AML.The applications of the novel polymeric fluoropyrimidine F10 in cancer treatment: current evidence.Role of altholactone in inducing type II apoptosis signalling pathway and expression of cancer-related genes in cervical carcinoma HeLa cell line.Expression of a passenger miR-9* predicts favorable outcome in adults with acute myeloid leukemia less than 60 years of age.
P2860
Overexpression of MN1 confers resistance to chemotherapy, accelerates leukemia onset, and suppresses p53 and Bim induction
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Overexpression of MN1 confers ...... ppresses p53 and Bim induction
@ast
Overexpression of MN1 confers ...... ppresses p53 and Bim induction
@en
Overexpression of MN1 confers ...... ppresses p53 and Bim induction
@nl
type
label
Overexpression of MN1 confers ...... ppresses p53 and Bim induction
@ast
Overexpression of MN1 confers ...... ppresses p53 and Bim induction
@en
Overexpression of MN1 confers ...... ppresses p53 and Bim induction
@nl
prefLabel
Overexpression of MN1 confers ...... ppresses p53 and Bim induction
@ast
Overexpression of MN1 confers ...... ppresses p53 and Bim induction
@en
Overexpression of MN1 confers ...... ppresses p53 and Bim induction
@nl
P2860
P921
P1433
P1476
Overexpression of MN1 confers ...... ppresses p53 and Bim induction
@en
P2860
P304
P356
10.1371/JOURNAL.PONE.0043185
P407
P577
2012-01-01T00:00:00Z